Literature DB >> 12813028

Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis.

Wanhong Ding1, Stefan Beissert, Liang Deng, Edward Miranda, Christopher Cassetty, Kristina Seiffert, Kristina L Campton, Zhengmin Yan, George F Murphy, Jeffrey A Bluestone, Richard D Granstein.   

Abstract

IL-10 is a pleiotropic cytokine that inhibits several immune parameters, including Th1 cell-mediated immune responses, antigen presentation, and antigen-specific T cell proliferation. Recent data implicate IL-10 as a mediator of suppression of cell-mediated immunity induced by exposure to UVB radiation (280-320 nm). To investigate the effects of IL-10 on the cutaneous immune system, we engineered transgenic mice that overexpress viral IL-10 (vIL-10) in the epidermis. vIL-10 transgenic mice demonstrated a reduced number of I-A(+) epidermal and dermal cells and fewer I-A(+) hapten-bearing cells in regional lymph nodes after hapten painting of the skin. Reduced CD80 and CD86 expression by I-A(+) epidermal cells was also observed. vIL-10 transgenic mice demonstrated a smaller delayed-type hypersensitivity response to allogeneic cells upon challenge but had normal contact hypersensitivity to an epicutaneously applied hapten. Fresh epidermal cells from vIL-10 transgenic mice showed a decreased ability to stimulate allogeneic T cell proliferation, as did splenocytes. Additionally, chronic exposure of mice to UVB radiation led to the development of fewer skin tumors in vIL-10 mice than in WT controls, and vIL-10 transgenic mice had increased splenic NK cell activity against YAC-1targets. These findings support the concept that IL-10 is an important regulator of cutaneous immune function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813028      PMCID: PMC161417          DOI: 10.1172/JCI15722

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18.

Authors:  G Cai; R A Kastelein; C A Hunter
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

2.  Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.

Authors:  Karl G Parato; Ashok Kumar; Andrew D Badley; Jaime L Sanchez-Dardon; Kelley A Chambers; Charlene D Young; Wilfred T Lim; Stephen Kravcik; D William Cameron; Jonathan B Angel
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

3.  Studies of delayed systemic effects of ultraviolet B radiation (UVR) on the induction of contact hypersensitivity, 2. Evidence that interleukin-10 from UVR-treated epidermis is the critical mediator.

Authors:  I Kurimoto; T Kitazawa; J W Streilein
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10.

Authors:  H Niizeki; J W Streilein
Journal:  J Invest Dermatol       Date:  1997-07       Impact factor: 8.551

5.  Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer.

Authors:  K N Kim; S Watanabe; Y Ma; S Thornton; E H Giannini; R Hirsch
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

6.  UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses.

Authors:  J Garssen; R J Vandebriel; F R De Gruijl; D A Wolvers; M Van Dijk; A Fluitman; H Van Loveren
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.

Authors:  T Takayama; H Tahara; A W Thomson
Journal:  Transplantation       Date:  2001-05-15       Impact factor: 4.939

8.  Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10.

Authors:  L Cervenak; L Morbidelli; D Donati; S Donnini; T Kambayashi; J L Wilson; H Axelson; E Castaños-Velez; H G Ljunggren; R D Malefyt; H J Granger; M Ziche; M T Bejarano
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

9.  Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice.

Authors:  S Beissert; J Hosoi; R Kühn; K Rajewsky; W Müller; R D Granstein
Journal:  J Invest Dermatol       Date:  1996-10       Impact factor: 8.551

10.  Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.

Authors:  Y Ma; S Thornton; L E Duwel; G P Boivin; E H Giannini; J M Leiden; J A Bluestone; R Hirsch
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

View more
  4 in total

1.  Ultraviolet B irradiation selectively increases the production of interleukin-8 in human cord blood-derived mast cells.

Authors:  I Endoh; N Di Girolamo; T Hampartzoumian; B Cameron; C L Geczy; N Tedla
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 2.  Lymphatic Function in Autoimmune Diseases.

Authors:  Noa Schwartz; Madhavi Latha S Chalasani; Thomas M Li; Zhonghui Feng; William D Shipman; Theresa T Lu
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

Review 3.  Immune Cell-Stromal Circuitry in Lupus Photosensitivity.

Authors:  Ji Hyun Sim; William G Ambler; Isabel F Sollohub; Mir J Howlader; Thomas M Li; Henry J Lee; Theresa T Lu
Journal:  J Immunol       Date:  2021-01-15       Impact factor: 5.422

4.  Photoprotective and immunoregulatory capacity of ginsenoside Rg1 in chronic ultraviolet B-irradiated BALB/c mouse skin.

Authors:  Jin-Shu Lou; Xiao-E Chen; Yan Zhang; Zuo-Wen Gao; Tai-Ping Chen; Guo-Qiang Zhang; Chang Ji
Journal:  Exp Ther Med       Date:  2013-07-25       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.